Ana Santander-Fernandez

La Paz, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants.

Journal: The pharmacogenomics journal

Published: February 19, 2026

Tumour SNPs Associated with Immune-Related Hepatitis in Patients with Melanoma Receiving Immune Checkpoint Inhibitors.

Tumour SNPs Associated with Immune-Related Hepatitis in Patients with Melanoma Receiving Immune Checkpoint Inhibitors.

Journal: Biomedicines

Published: July 22, 2025

Worldwide distribution of genetic factors related to severity of COVID-19 infection.

Worldwide distribution of genetic factors related to severity of COVID-19 infection.

Journal: Annals of human biology

Published: July 16, 2024

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment.

HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment.

Journal: Cancers

Published: December 16, 2022

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer.

FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer.

Journal: Pharmaceutics

Published: November 22, 2021

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer.

miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer.

Journal: Pharmacogenomics and personalized medicine

Published: April 02, 2021

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.

Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.

Journal: International journal of molecular sciences

Published: January 07, 2021

Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer.

Role of Chromodomain-Helicase-DNA-Binding Protein 4 (CHD4) in Breast Cancer.

Journal: Frontiers in oncology

Published: November 24, 2020

Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports.

Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports.

Journal: World journal of gastroenterology

Published: January 07, 2020

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer.

Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer.

Journal: Journal of oncology

Published: October 28, 2019

UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data.

UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data.

Journal: Annals of human biology

Published: January 09, 2019

Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types.

Differential expression of PMCA2 mRNA isoforms in a cohort of Spanish patients with breast tumor types.

Journal: Oncology letters

Published: January 29, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026